Quo-Test®: Lab-accurate HbA1c results
The Quo-Test® is a fully automated desktop point-of-care HbA1c analyzer. It will give easy and reliable HbA1c measurement for the monitoring and management of diabetes in a point-of-care setting, such as diabetes clinics and doctors’ surgeries.
The supplier does not provide quotations for this product through SelectScience. You can search for similar products in our Product Directory.
Great result can not be without this instrument for HbA1c test.
Analyze HbA1c
Easy to use, but a time consuming product. No missing chance - gives two main benifits, A1C & 3RBS result. These instruments are are a good choice for handling. We are very happy with service support.
Review Date: 25 Jun 2020 | EKF Diagnostics
The Quo-Test® HbA1c system is a fully automated hemoglobin A1c analyzer that uses patented boronate affinity fluorescence quenching technology to measure glycated hemoglobin from a 4 μl sample of capillary or venous whole blood. Sample results are available within four minutes and are dual-reported in IFCC and DCCT standard units (Mono S & JDS reporting are also available). Quo-Test® uses the boronate affinity method which is recognized as interference-free.
Quo-Test® can store up to 7,000 results, which can be downloaded as text files to a PC via the integrated USB interface or through the Quo-Connect and EKF Link. Alternatively, results can be printed using a printer that connects via a serial port.
The analyzers’ clear, multi-lingual display displays step-by-step instructions, reducing staff training time to a minimum and almost eliminating the opportunity for user-related errors.
Key Features:
• Fully automates analyzer
• Fast and accurate
• Results in just 4 minutes
• Just 4ul blood required from finger prick or venous sample
Please note: Not all products are available in all countries. Please check with EKF for availability.
Evaluation of four POCT-Systems for the Measurement of HbA1c
Point of care testing (POCT) of HbA1c, an internationally recognized biomarker of blood glucose levels for diabetes management, offers significant advantages to the patient by enabling real-time monitoring and management of the condition. This whitepaper summarizes a study to compare 4 POCT methods with established laboratory techniques for the determination of HbA1c.
Quo-Test desktop HbA1c analyzer with EKF Link
EKF Diagnostics presents the Quo-Test®, a fully automated desktop HbA1c analyzer. Discover how this easy-to-use device provides accurate HbA1c measurements, making it ideal for monitoring and managing diabetes in point-of-care settings, such as diabetes clinics and doctor’s offices. Quo-Test® can store up to 7,000 results, which can be downloaded as text files to a PC via the integrated USB interface or through the Quo-Connect and EKF Link. Alternatively, results can be printed using a printer that connects via a serial port.
EKF Diagnostics acquires ADL Health molecular diagnostic testing laboratory
New testing capacity complements EKF’s test kit manufacturing and point-of-care diagnostic instrument business
Distribution agreement expands HbA1c POC testing reach in Middle East & Africa
Leading HPLC analyzer manufacturer Tosoh Europe partners with EKF for Quo-Test HbA1c point-of-care analyzer
Diabetes Research Unit Cymru confirms EKF POCT HbA1c testing comparable to lab-based HPLC
EKF Quo-Test HbA1c analyzer successfully evaluated at Swansea University Diabetes Research Unit
EKF Showcases New Connectivity Solution for Point-of-Care HbA1c Analyzers at Medica 2016
EKF’s Quo-Test™ and Quo-Lab™ now come with a connectivity package allowing these point-of-care HbA1c analyzers to transmit patient data to the majority of LIMS and HIS
EKF Diagnostics to Showcase Comprehensive Clinical Chemistry Range at AACC 2015
To find out more about their comprehensive range of clinical chemistry, visit them at booth #1018.
In Profile: EKF Diagnostics
Building an international diagnostics company
